Conrad P. Dorn

1.2k total citations
30 papers, 891 citations indexed

About

Conrad P. Dorn is a scholar working on Organic Chemistry, Cancer Research and Molecular Biology. According to data from OpenAlex, Conrad P. Dorn has authored 30 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Conrad P. Dorn's work include Carbohydrate Chemistry and Synthesis (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Peptidase Inhibition and Analysis (7 papers). Conrad P. Dorn is often cited by papers focused on Carbohydrate Chemistry and Synthesis (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Peptidase Inhibition and Analysis (7 papers). Conrad P. Dorn collaborates with scholars based in United States. Conrad P. Dorn's co-authors include Bonnie M. Ashe, Manuel A. Navia, James P. Springer, H R Williams, Tsau-Yen Lin, M.D. Zimmerman, Brian M. McKeever, Karst Hoogsteen, Eugene M. Fluder and Gilbert O. Chandler and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Conrad P. Dorn

30 papers receiving 832 citations

Peers

Conrad P. Dorn
Tsau-Yen Lin United States
Chih-Min Kam United States
Anne M. Strimpler United States
Claire A. Minshull United Kingdom
A.G. Pavlovsky United States
Bruce Gomes United States
Guixian Jin United States
Baoguang Zhao United States
Tsau-Yen Lin United States
Conrad P. Dorn
Citations per year, relative to Conrad P. Dorn Conrad P. Dorn (= 1×) peers Tsau-Yen Lin

Countries citing papers authored by Conrad P. Dorn

Since Specialization
Citations

This map shows the geographic impact of Conrad P. Dorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad P. Dorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad P. Dorn more than expected).

Fields of papers citing papers by Conrad P. Dorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad P. Dorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad P. Dorn. The network helps show where Conrad P. Dorn may publish in the future.

Co-authorship network of co-authors of Conrad P. Dorn

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad P. Dorn. A scholar is included among the top collaborators of Conrad P. Dorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad P. Dorn. Conrad P. Dorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Hongjian, Pasquale P. Vicario, Hans J. Zweerink, et al.. (2003). Expression and characterization of the chemokine receptor CCR2B from rhesus monkey. Biochemical Pharmacology. 66(2). 321–330. 3 indexed citations
2.
3.
Pacholok, Stephen G, Philip R. Davies, Conrad P. Dorn, et al.. (1995). Formation of polymorphonuclear leukocyte elastase: α1 proteinase inhibitor complex and Aα(1–21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. Biochemical Pharmacology. 49(10). 1513–1520. 10 indexed citations
4.
Chabin, Renee M., Philip A. Gale, Alan L. Maycock, et al.. (1993). Mechanism of inhibition of human leukocyte elastase by monocyclic .beta.-lactams. Biochemistry. 32(34). 8970–8980. 19 indexed citations
5.
Hagmann, William K., Shrenik K. Shah, Paul E. Finke, et al.. (1993). Orally active .beta.-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitution. Journal of Medicinal Chemistry. 36(6). 771–777. 22 indexed citations
6.
Mills, Sander G., Malcolm MacCoss, Richard J. Budhu, et al.. (1993). 1,4-Diacylpiperazine-2-(S)-[(N-aminoalkyl)carboxamides] as novel, potent substance P receptor antagonists.. Bioorganic & Medicinal Chemistry Letters. 3(12). 2707–2712. 12 indexed citations
7.
Shah, S. K., et al.. (1992). Orally active .beta.-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinones. Journal of Medicinal Chemistry. 35(21). 3745–3754. 63 indexed citations
8.
Knight, Wilson B., Renee M. Chabin, Philip A. Gale, et al.. (1992). Specificity, stability, and potency of monocyclic .beta.-lactam inhibitors of human leukocyte elastase. Biochemistry. 31(35). 8160–8170. 45 indexed citations
9.
Davies, Philip R., Bonnie M. Ashe, Robert J. Bonney, et al.. (1991). The Discovery and Biologic Properties of Cephalosporin‐Based Inhibitors of PMN Elastase. Annals of the New York Academy of Sciences. 624(1). 219–229. 24 indexed citations
10.
Doherty, James B., Bonnie M. Ashe, Peter L. Barker, et al.. (1990). Inhibition of human leukocyte elastase. 1. Inhibition by C-7-substituted cephalosporin tert-butyl esters. Journal of Medicinal Chemistry. 33(9). 2513–2521. 63 indexed citations
11.
Navia, Manuel A., Brian M. McKeever, James P. Springer, et al.. (1989). Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution.. Proceedings of the National Academy of Sciences. 86(1). 7–11. 205 indexed citations
12.
Williams, H R, Tsau-Yen Lin, Manuel A. Navia, et al.. (1987). Crystallization of human neutrophil elastase.. Journal of Biological Chemistry. 262(35). 17178–17181. 12 indexed citations
13.
Doherty, James B., Bonnie M. Ashe, Lawrence W. Argenbright, et al.. (1986). Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase. Nature. 322(6075). 192–194. 134 indexed citations
14.
Hagmann, William K., Conrad P. Dorn, Robert A. Frankshun, et al.. (1986). Synthesis and antiinflammatory/analgesic activities of 11H-dibenzo[b,e]dioxepinacetic acids. Journal of Medicinal Chemistry. 29(8). 1436–1441. 3 indexed citations
15.
Graham, P.M., et al.. (1985). Novel nucleophilic substitution of alkyl bromo‐2(1H)‐pyridones. Journal of Heterocyclic Chemistry. 22(2). 265–272. 5 indexed citations
16.
Durette, Philippe L., Conrad P. Dorn, T. Y. Shen, & Arthur Friedman. (1982). Synthesis and immunoadjuvant activity of 2-acetamido-1,5-anhydro-2-deoxy-3-O-[(R)-2-propanoyl-l-alanyl-d-isoglutamine]-d-glucitol (“1-deoxymuramoyl dipeptide”) and its 6-(2-behenoyloxyisobutyrate). Carbohydrate Research. 108(1). 139–147. 8 indexed citations
17.
Zimmerman, M.D., J. P. Quigley, Bonnie M. Ashe, et al.. (1978). Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.. Proceedings of the National Academy of Sciences. 75(2). 750–753. 85 indexed citations
18.
Dorn, Conrad P., et al.. (1977). Synthesis of 25-fluorovitamin D3. Tetrahedron Letters. 18(27). 2315–2316. 5 indexed citations
19.
Doorenbos, Norman J. & Conrad P. Dorn. (1962). Steroids IX. Journal of Pharmaceutical Sciences. 51(5). 414–417. 9 indexed citations
20.
Doorenbos, Norman J. & Conrad P. Dorn. (1961). Steroids VI. Thiazoloandrostanes. Journal of Pharmaceutical Sciences. 50(3). 271–271. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026